Delivery Order SPE2DB25D3020-SPE2DB25FWHSB

Award Date 5/23/25
Potential Completion Date 5/27/25
Potential Value $1.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $1,179.14 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a diabetes medication. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support...
This is a $1,498.84 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a medication used to treat diabetes. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical for providing a comprehensive range...
This is a $3,963.52 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML medical supplies. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,881.20 firm fixed-price contract is for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a diabetes medication, to support military healthcare programs. The contract has an ultimate completion date of January 3, 2024. This delivery order is part of a larger Indefinite Delivery...
This is a $1,647.80 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a prescription medication used to treat diabetes. This delivery order was placed under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables DLA to efficiently procure a...
This is a $8,455.38 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The order is for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a type of insulin medication. The contract has an ultimate completion date of August 19, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,027.84 contract is for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a specialty medication product. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which covers a...
This is a $4,479.97 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML medical products. It has an ultimate completion date of March 19, 2025 and is not associated with any set-aside designation. The contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This is a $6,210.85 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for 4,565,705,621 units of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a prescription medication. The contract has an ultimate completion date of September 9, 2024 and does not utilize a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, under the company's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999. The delivery order is for LANTUS SOLOSTAR 100 UNIT/ML 3ML, a prescription medication, at a ceiling value of $1,891.12. The contract has a firm fixed price and a period of performance through November 2024. The delivery order does not have a...
  • SPE2DB25D3020
    Indefinite Delivery Contract
  • SPE2DB25D3020-SPE2DB25FWHSB
    Delivery Order

This is a $1,837.60 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a diabetes medication. The delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides global pharmaceutical support to military healthcare programs. The contract has an ultimate completion date of May 27, 2025 and is not designated as a set-aside.

Generated 8/22/25, 9:44 AM